International beauty giant L’Oréal is set to expand its portfolio by acquiring a majority stake in UK-based premium skincare brand Medik8 from the mid-market private equity firm Inflexion. While specific terms of the transaction remain undisclosed, reports suggest the deal is estimated to be valued at approximately €1 billion (about $1.14 billion). Leading the legal advisory for the transaction, A&O Shearman has appointed M&A partners Matthew Appleton and Aoife McDermott to spearhead its team in London. They are supported by colleagues specializing in corporate tax, incentives, and antitrust across London and Paris.
Taylor Wessing’s corporate and private equity partners Jonny Bethell and James Goold represent the interests of Inflexion. The transaction underscores the strategic moves of leading law firms and their pivotal roles in guiding high-value corporate deals.
More details can be accessed through the original article.